Put companies on watchlist
MEDICLIN AG
ISIN: DE0006595101
WKN: 659510
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

MEDICLIN AG · ISIN: DE0006595101 · EQS - Company News (52 News)
Country: Germany · Primary market: Germany · EQS NID: 1874595
05 April 2024 03:09PM

MEDICLIN buys Reha-Klinik am Sendesaal


EQS-News: MEDICLIN AG / Key word(s): Expansion/Contract
MEDICLIN buys Reha-Klinik am Sendesaal

05.04.2024 / 15:09 CET/CEST
The issuer is solely responsible for the content of this announcement.


MEDICLIN buys Reha-Klinik am Sendesaal
The purchase agreement for the rehabilitation clinic in Bremen was signed today

Offenburg, 5 April 2024 - As of today, it's official: MEDICLIN is buying the Reha-Klinik am Sendesaal, which previously belonged to the Specht Group. The purchase agreement was signed this morning in Bremen.

"We warmly welcome the employees of the Reha-Klinik am Sendesaal", says Dr Joachim Ramming, CEO of MEDICLIN. "Rehabilitation is our core competence and we look forward to shaping the rehabilitation of the future together with the employees in Bremen!" The existing employment relationships are to be retained unchanged. A transfer of operations is planned for the second quarter.

Thomas Piefke, COO at MEDICLIN and responsible for the Rehab division, emphasises: "As part of our rehab strategy, we are in the process of expanding our structures in the ambulatory and - where appropriate - stationary areas. The Reha-Klinik am Sendesaal is a very good fit for our Group, both with its specialised areas and its mix of stationary and ambulatory services."

In future, the clinic will be managed by Holger Kammann, who is also Regional Managing Director and Head of the MEDICLIN Hedon Clinic in Lingen. "I'm looking forward to getting to know the staff at the Reha-Klinik am Sendesaal in the coming weeks and months and to travelling the path ahead together," says Kammann.

About the Rehabilitation Clinic at the Sendesaal
The Reha-Klinik am Sendesaal is an interdisciplinary clinic for inpatient and outpatient rehabilitation with the indications cardiology, orthopaedics and geriatrics. With 174 inpatient beds and up to 70 outpatient places, it covers a cross-indication rehabilitation spectrum.

For further information:

MEDICLIN Aktiengesellschaft
Okenstrasse 27
77652 Offenburg

Investor Relations
Ender Gülcan
Phone: 0781/488-326
Fax: 0781/488-184
ender.guelcan@mediclin.de


Public Relations
Dr Janina Lossen
Phone: 0781/488-180
janina.lossen@mediclin.de

www.mediclin.de



About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 32 clinics, six care facilities and ten medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.

MEDICLIN ─ a company of the Asklepios Group
 


05.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: MEDICLIN AG
Okenstraße 27
77652 Offenburg
Germany
Phone: +49 (0)781 488-326
Fax: +49 (0)781 488-184
E-mail: ender.guelcan@mediclin.de
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1874595

 
End of News EQS News Service

1874595  05.04.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1874595&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - MEDICLIN AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.